1,538 results on '"Djulbegovic, Benjamin"'
Search Results
152. Evidence-based medicine in times of crisis
153. Research synthesis of information theory measures of uncertainty: Meta‐analysis of entropy and mutual information of diagnostic tests
154. Evaluation of the U.S. governors' decision when to issue stay‐at‐home orders
155. Defining Undertreatment and Overtreatment in Older Adults With Cancer: A Scoping Literature Review
156. Meta-Analysis of mutual information applied in EBM diagnostics
157. Complex Oncological Decision-Making Utilizing Fast-and-Frugal Trees in a Community Setting—Role of Academic and Hybrid Modeling
158. Efficacy of daratumumab in the treatment of multiple myeloma with high-risk cytogenetics: Meta-analysis of randomized phase III trials.
159. Evaluation of the US governors decision when to issue stay-at-home orders [Running title: When to shut down: the Weber-Fechner law describes the timing of U. S. governors decisions to issue stay-at-home orders]
160. In reply
161. Diagnostic Predictive Model for Diagnosis of Heart Failure after Hematopoietic Cell Transplantation (HCT): Comparison of Traditional Statistical with Machine Learning Modeling
162. Re: Tandem vs Single Autologous Hematopoietic Cell Transplantation for the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis
163. Risk Prediction Versus Diagnosis: Classification of Borderline Cases in a Binary World
164. Tandem Versus Single Autologous Hematopoietic Cell Transplantation for the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis
165. Erythropoietin use in oncology: a summary of the evidence and practice guidelines comparing efforts of the Cochrane Review group and Blue Cross/Blue Shield to set up the ASCO/ASH guidelines
166. Treatment Success in Cancer
167. Unprocessed red meat and processed meat consumption: Dietary guideline recommendations from the NutriRECS Consortium
168. Estimating Net Benefits and Harms of Screening Mammography in Women Age 40 to 49 Years
169. Systematic review of high dose chemotherapy and autologous haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: what is the published evidence?
170. Evaluation of Serious Adverse Drug Reactions: A Proactive Pharmacovigilance Program (RADAR) vs Safety Activities Conducted by the Food and Drug Administration and Pharmaceutical Manufacturers
171. Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
172. Evidence and decision making. Commentary on M.R. Tonelli (2006), Integrating evidence into clinical practice: an alternative approach to evidence-based approaches. Journal of Evaluation in Clinical Practice 12, 248–256
173. Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients
174. Misleading Statements in Industry-Sponsored Meta-Analysis of Itraconazole
175. Is the Statistical Difference Clinically Relevant?
176. Acting on Imperfect Evidence: How Much Regret Are We Ready to Accept?
177. Colony-Stimulating Factors for Chemotherapy-Induced Febrile Neutropenia: A Meta-Analysis of Randomized Controlled Trials
178. Evaluation of New Treatments in Radiation Oncology: Are They Better Than Standard Treatments?
179. Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits farnesylation and oncogenic/tumor survival pathways in patients with advanced multiple myeloma
180. Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update.
181. When are randomized trials unnecessary? A signal detection theory approach to approving new treatments based on non‐randomized studies.
182. Well informed uncertainties about the effects of treatment: Paradox exists in dealing with uncertainty
183. Itraconazole Prevents Invasive Fungal Infections in Neutropenic Patients Treated for Hematologic Malignancies: Evidence From a Meta-Analysis of 3,597 Patients
184. Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group
185. Use of Epoetin in Patients With Cancer: Evidence-Based Clinical Practice Guidelines of the American Society of Clinical Oncology and the American Society of Hematology
186. At what degree of belief in a research hypothesis is a trial in humans justified?
187. Proposal for Development of EBM-CDSS (Evidence-based Clinical Decision Support System) to Aid Prognostication in Terminally Ill Patients
188. Ethical Issues in the Reporting of Clinical Trials
189. A data-mining approach to improving Polycythemia Vera diagnosis
190. Placebo-Controlled Trials
191. Informing Patients of Uncertainty in Clinical Trials
192. Prophylactic granulocyte colony-stimulating factor in patients receiving dose-intensive cancer chemotherapy: a meta-analysis
193. Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis
194. Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
195. Uncertainty about clinical equipoise : Equipoise and uncertainty principle are not mutually exclusive
196. Scientific and Ethical Issues in Equivalence Trials
197. Management of multiple myeloma: a systematic review and critical appraisal of published studies
198. Industry-sponsored research
199. The uncertainty principle and industry-sponsored research
200. Acquired anaemias and polycythaemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.